Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction
Xiao Z, Kong B, Fang J, Qin T, Dai C, Shuai W, Huang H. Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction. Bioengineered. 2021 Dec;12(2):9367-9376.
Rat
Cardiovascular Diseases
2021
Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway
Lei Q, Yu Z, Li H, Cheng J, Wang Y. Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway. J Adv Res. 2022 Sep;40:197-206.
Mouse
Cardiovascular Diseases
2021
Noise exposure and its relationship with postinfarction cardiac remodeling: implications for NLRP3 inflammasome activation
Wei Y, Li W, Yang S, Zhong P, Bi Y, Tang Y. Noise exposure and its relationship with postinfarction cardiac remodeling: implications for NLRP3 inflammasome activation. Bioengineered. 2022 May;13(5):12127-12140.
Rat
Cardiovascular Diseases
2022
Chronic Sigma 1 receptor activation alleviates right ventricular dysfunction secondary to pulmonary arterial hypertension
Sun Y, Wan W, Zhao X, Han X, Ye T, Chen X, Ran Q, Wang X, Liu X, Qu C, Shi S, Zhang C, Yang B. Chronic Sigma 1 receptor activation alleviates right ventricular dysfunction secondary to pulmonary arterial hypertension. Bioengineered. 2022 Apr;13(4):10843-10856.
Rat
Cardiovascular Diseases
2022
Microglia‐Mediated Neuroimmune Response Regulates Cardiac Remodeling After Myocardial Infarction
Wang M, Zhang J, Yin Z, Ding W, Zhao M, Liu J, Xu Y, Xu S, Pan W, Wei C, Jiang H, Wan J. Microglia-Mediated Neuroimmune Response Regulates Cardiac Remodeling After Myocardial Infarction. J Am Heart Assoc. 2023 Jun 20;12(12):e029053.
Mouse
Cardiovascular Diseases
2023
Mettl3 deficiency leads to the upregulation of Cav1.2 and increases arrhythmia susceptibility in mice
Shi L, Jin X, Li Z, Gong R, Guo Y, Ma J, Zhang Y, Cai B, Yang B, Gong D, Pan Z. Mettl3 deficiency leads to the upregulation of Cav1.2 and increases arrhythmia susceptibility in mice. Acta Biochim Biophys Sin (Shanghai). 2022 Jan 25;54(2):199-208.
Mouse
Cardiovascular Diseases
2022
